|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Dez―18 |
Temporal, spatial and demographic distributions characteristics of COVID-19 symptom clusters from chinese medicine perspective: a systematic cross-sectional study in China from 2019 to 2023 |
Bin Liu, Tian Song, Mingzhi Hu, Zhaoyuan Gong, Qianzi Che, Jing Guo, et al. (+9) Lin Chen, Haili Zhang, Huizhi Li, Ning Liang, Jing Wan, Kunfeng Wang, Yanping Wang, Nannan Shi, Luqi Huang |
2 |
[GO] |
2024―Jan―23 |
The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in Macao |
Hui Mo, Man-Fei Zhou, Edmundo Patricio Lopes Lao, Ka-Kei Chan, On-Na Lai, Man-In Ho, et al. (+7) Kin-Wa Wong, Ka-Meng Ho, Kin-Tim Sio, Keng-Lam Fong, Yong-Hua Zhao, Seng-Ip Cheang, Iek-Long Lo |
3 |
[GO] |
2023―Aug―02 |
Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro |
Min Zhang, Liting Liu, Yao Zhao, Yipeng Cao, Yan Zhu, Lifeng Han, et al. (+6) Qi Yang, Yu Wang, Changjian Wang, Han Zhang, Yuefei Wang, Junhua Zhang |
4 |
[GO] |
2022―Okt―28 |
Effectiveness and safety research of Qingfei Paidu (QFPD) in treatment of COVID-19: an up-to-date systematic review and meta-analysis |
Xinxin Wang, Tao Ma, Wei Zhang, Qiang Chu |
5 |
[GO] |
2022―Okt―24 |
Correction: Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study |
Linda Li-Dan Zhong, Yi-Ping Wong, Chor-Yin Leung, Bo Peng, Zhi-Xiu Lin, Vivian Chi-Woon Wong Taam, et al. (+15) Yi Luo, Hai-Yong Chen, Chao-Dong Chao, Chor-Fung Wong, Freddie Shung-Chi Tam, Kui Chan, Kwan-Yiu Lee, Lai-Fun Ho, Alan Yat-Lun Wong, Chi-Fung Choy, Bacon Fung-Leung Ng, Rowena How-Wan Wong, Yi-Bin Feng, Ching Liong, Zhao-Xiang Bian |
6 |
[GO] |
2022―Aug―22 |
Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study |
Linda Li-Dan Zhong, Yi-Ping Wong, Chor-Yin Leung, Bo Peng, Zhi-Xiu Lin, Vivian Chi-Woon Wong Taam, et al. (+15) Yi Luo, Hai-Yong Chen, Chao-Dong Chao, Chor-Fung Wong, Freddie Shung-Chi Tam, Kui Chan, Kwan-Yiu Lee, Lai-Fun Ho, Alan Yat-Lun Wong, Chi-Fung Choy, Bacon Fung-Leung Ng, Rowena How-Wan Wong, Yi-Bin Feng, Ching Liong, Zhao-Xiang Bian |
7 |
[GO] |
2022―Jul―27 |
An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding |
Ka Man Yip, Kwan Ming Lee, Tzi Bun Ng, Shujun Xu, Ken Kin Lam Yung, Shaogang Qu, et al. (+2) Allen Ka Loon Cheung, Stephen Cho Wing Sze |
8 |
[GO] |
2022―Jul―07 |
Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19 |
Liang Hong, Min He, Shaoping Li, Jing Zhao |
9 |
[GO] |
2022―Jun―21 |
The efficacy and safety of combined chinese herbal medicine and western medicine therapy for COVID-19: a systematic review and meta-analysis |
Lu Li, Hongliang Xie, Ling Wang, Aolin Zhang, Xuan Mou, Yifan Lin, et al. (+8) Hongli Ma, Yu Wang, Jian Li, Jingshu Gao, Chi Chiu Wang, Ping Chung Leung, Xiaohui Fan, Xiaoke Wu |
10 |
[GO] |
2022―Apr―02 |
Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial |
Xuedong An, Bo Peng, Xiaodong Huang, Hongmei Jiang, Zhang’e Xiong, Hong Zhang, et al. (+3) Fengmei Lian, Yuanming Ba, Xiaolin Tong |
11 |
[GO] |
2022―Apr―01 |
Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro |
Qinhai Ma, Biao Lei, Ruihan Chen, Bin Liu, Wencong Lu, Haiming Jiang, et al. (+7) Zexing Chen, Xiaowen Guo, Yutao Wang, Lu Zhang, Qiaoyan Chen, Xiaobo Li, Zifeng Yang |
12 |
[GO] |
2022―Feb―28 |
Efficacy and mechanisms of traditional Chinese medicine for COVID-19: a systematic review |
Xiaomin Kang, De Jin, Linlin Jiang, Yuqing Zhang, Yuehong Zhang, Xuedong An, et al. (+6) Liyun Duan, Cunqing Yang, Rongrong Zhou, Yingying Duan, Yuting Sun, Fengmei Lian |
13 |
[GO] |
2021―Dez―03 |
Efficacy and potential mechanisms of Chinese herbal compounds in coronavirus disease 2019: advances of laboratory and clinical studies |
Mu-Feng Xiang, Cheng-Tao Jin, Li-Hua Sun, Zhi-Hui Zhang, Jing-Jing Yao, Liu-Cheng Li |
14 |
[GO] |
2021―Okt―18 |
The therapeutic promises of Lianhuaqingke in the mice model of coronavirus pneumonia (HCoV-229E and SARS-CoV-2) |
Mingye Wang, Wenyan Li, Wenwen Cui, Yuanyuan Hao, Yao Mi, Hongtao Wang, et al. (+2) Yunlong Hou, Zhenhua Jia |
15 |
[GO] |
2021―Jul―28 |
Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review |
Yadong Fan, Ying Wang, Shuang Yu, Jun Chang, Yiqi Yan, Yiyang Wang, Yuhong Bian |
16 |
[GO] |
2021―Jul―27 |
Current status of traditional Chinese medicine for the treatment of COVID-19 in China |
Liang Chu, Fang Huang, Mengdan Zhang, Biao Huang, Yigang Wang |
17 |
[GO] |
2021―Jun―07 |
The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19 |
Xuedong An, Liyun Duan, Yue Hong Zhang, De Jin, Shenghui Zhao, Rong Rong Zhou, et al. (+3) Yingying Duan, Fengmei Lian, Xiaolin Tong |
18 |
[GO] |
2021―Mrz―03 |
The important herbal pair for the treatment of COVID-19 and its possible mechanisms |
Shujie Xia, Zhangfeng Zhong, Bizhen Gao, Chi Teng Vong, Xuejuan Lin, Jin Cai, et al. (+3) Hanlu Gao, Ging Chan, Candong Li |
19 |
[GO] |
2021―Feb―22 |
Traditional Chinese herbal medicine-potential therapeutic application for the treatment of COVID-19 |
Jillian L. Capodice, Barbara M. Chubak |
20 |
[GO] |
2020―Sep―25 |
Applications, phytochemistry, pharmacological effects, pharmacokinetics, toxicity of Scutellaria baicalensis Georgi. and its probably potential therapeutic effects on COVID-19: a review |
Jia-Wen Song, Jia-Ying Long, Long Xie, Lin-Lin Zhang, Qing-Xuan Xie, Hui-Juan Chen, et al. (+2) Mao Deng, Xiao-Fang Li |
21 |
[GO] |
2020―Sep―03 |
Reflections on treatment of COVID-19 with traditional Chinese medicine |
Hua Luo, Yan Gao, Jian Zou, Siyuan Zhang, Hanbin Chen, Qiao Liu, et al. (+4) Dechao Tan, Yan Han, Yonghua Zhao, Shengpeng Wang |
22 |
[GO] |
2020―Jul―30 |
Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking |
Lin Han, Xiu-Xiu Wei, Yu-Jiao Zheng, Li-Li Zhang, Xin-Miao Wang, Hao-Yu Yang, et al. (+3) Xu Ma, Lin-Hua Zhao, Xiao-Lin Tong |
23 |
[GO] |
2020―Jul―09 |
Current strategies against COVID-19 |
Shahid Hussain, Ya-Jia Xie, Dan Li, Shaukat Iqbal Malik, Jin-cai Hou, Elaine Lai-Han Leung, Xing-Xing Fan |
24 |
[GO] |
2020―Jun―12 |
Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking |
Xiaofeng Ruan, Peng Du, Kang Zhao, Jucun Huang, Hongmei Xia, Dan Dai, et al. (+4) Shu Huang, Xiang Cui, Liming Liu, Jianjun Zhang |
25 |
[GO] |
2020―Jun―05 |
To Explore the Potential Mechanism of Yiqing Capsule in the Treatment of COVID-19 Based on Network Pharmacology |
Ying Wang, Jingyi Zhao, Yinhui Yao, Song Jiang, Xinhong Zhao, Junhui Hu |
26 |
[GO] |
2020―Jun―05 |
Body fluids may contribute to human-to-human transmission of severe acute respiratory syndrome coronavirus 2: evidence and practical experience |
Amir Hossein Mohseni, Sedigheh Taghinezhad-S, Zhigang Xu, Xiangsheng Fu |
27 |
[GO] |
2020―Jun―04 |
Exploration on Shufeng Jiedu Capsule for Treatment of COVID-19 Based on Network Pharmacology and Molecular Docking |
Yanwu Zhao, Junhui Hu, Jiang Song, Xinhong Zhao, Yanjing Shi, Yanping Jiang |
28 |
[GO] |
2020―Mai―28 |
Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment? |
Tuğçenur Uzun, Orcun Toptas |
29 |
[GO] |
2020―Mai―24 |
The potential insights of Traditional Chinese Medicine on treatment of COVID-19 |
Tong Tong, Ying-Qi Wu, Wei-Jian Ni, Ai-Zong Shen, Sheng Liu |
30 |
[GO] |
2020―Mai―14 |
Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection |
Yong Zeng, Bo Zhang, Xufeng Zhang, Cunjian Yi |
31 |
[GO] |
2020―Apr―15 |
Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China |
Erdan Luo, Daiyan Zhang, Hua Luo, Bowen Liu, Keming Zhao, Yonghua Zhao, et al. (+2) Ying Bian, Yitao Wang |